NCT03669328

Brief Summary

The effectiveness of the analgesic and anti-nausea prevention techniques of the investigators justifies being evaluated regularly in order to adapt the management strategy to the specificities of each surgical act. A first evaluation took place in June 2016 and allowed to identify a category of patients (partial breast surgery with or without axillary gesture) not benefiting from an ideal algological management because justifying in 30% of the cases of a level 3 analgesic remedy in the postoperative recovery room. This use of morphine results in a significant incidence of postoperative nausea and prolonged recovery time before return home harmful to the patient. With their experience in locoregional anesthesia technique in complete breast surgery (total mastectomy) and aware of the effectiveness of this type of anesthesia on the management of immediate and chronic pain, the investigators have extended their indications of ALR to partial breast surgery in ambulatory.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2016

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 13, 2018

Completed
Last Updated

September 13, 2018

Status Verified

August 1, 2018

Enrollment Period

29 days

First QC Date

August 30, 2018

Last Update Submit

September 11, 2018

Conditions

Keywords

Surgerycanceranesthesiapainoutcome patientPostoperative Nausea and Vomiting

Outcome Measures

Primary Outcomes (1)

  • Evaluation of pain after surgery by Simple Verbal Evaluation

    Pain level in post-operative room measured by Simple Verbal Evaluation. The simple verbal scale or Keele scale has 5 qualifiers to describe the intensity of the pain, each descriptor is associated with a numerical value. 0 = no pain, 1 = poor, 2 = moderate, 3 = intense, 4 = atrocious. The goal of management is to achieve pain values below 3 (low to moderate).

    1 day (the day of the surgery)

Secondary Outcomes (7)

  • Incidence of postopérative nausea and vomiting after prevention strategy guided by Apfel score risk

    1 day before surgery

  • Medical procedure characteristics

    1 day (the day of the surgery)

  • Evaluation of pain after surgery by Opioid requirements

    3 days (from surgery to 3 days after)

  • Evaluation of home-based return capability by CHUNG score

    1 day (just after the surgery)

  • Evaluation of pain at home after surgery at mobility by EVA during the first 3 days

    3 days (from surgery to 3 days after)

  • +2 more secondary outcomes

Study Arms (2)

Group 1

patients of 2016, June with locoregional anesthesia

Procedure: locoregional anesthesia

Group 2

patients of 2018, June with locoregional anesthesia

Procedure: locoregional anesthesia

Interventions

Both groups received locoregional anesthesias

Group 1Group 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

During the period from 01 to 30 June 2016, all patients admitted for ambulatory surgery under general anesthesia were included in this prospective "before-after" study. To have two perfectly comparable populations, we chose to reassess all patients in outpatient surgery combined, on the second period (18 to 5 July 2018), even if our changes of care only concerns breast.

You may qualify if:

  • patients admitted for ambulatory surgery under general anesthesia
  • patients admitted during the period from 01 to 30 June 2016 or during the period from 18 to 5 July 2018

You may not qualify if:

  • Patient neither French nor English,
  • Patient refusing to participate in this study
  • Minor patients were excluded to ensure the homogeneity of the surveyed population (satisfaction of minors not meeting the same characteristics as that of adults)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Claudius Regaud

Toulouse, Occitanie, 31100, France

Location

Related Publications (5)

  • Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009 Nov 11;302(18):1985-92. doi: 10.1001/jama.2009.1568.

  • Fuzier R, Puel F, Izard P, Sommet A, Pierre S. Prospective cohort study assessing chronic pain in patients following minor surgery for breast cancer. J Anesth. 2017 Apr;31(2):246-254. doi: 10.1007/s00540-016-2288-9. Epub 2016 Nov 24.

  • Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012 Nov;59(9):470-5. doi: 10.1016/j.redar.2012.07.003. Epub 2012 Aug 29.

  • Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lanteri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005 Mar;114(1-2):29-36. doi: 10.1016/j.pain.2004.12.010. Epub 2005 Jan 26.

  • Kumar SP. Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review. Indian J Palliat Care. 2011 May;17(2):108-15. doi: 10.4103/0973-1075.84531.

MeSH Terms

Conditions

NeoplasmsPainPostoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesNauseaSigns and Symptoms, DigestiveVomiting

Study Officials

  • Amel Daboussi, PhD

    Institut Claudius Regaud

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2018

First Posted

September 13, 2018

Study Start

June 1, 2016

Primary Completion

June 30, 2016

Study Completion

June 30, 2018

Last Updated

September 13, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations